ArriVent BioPharma, Inc. business relationships
Companies named in ArriVent BioPharma, Inc.’s 10-K filed 2026-03-05, and public companies whose annual reports name ArriVent BioPharma, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.6 / 10
- AI naming
- 3 / 100 Top 4% in its category
- Agent readiness
- 25 / 100
- AI adoption
- 0 / 100
Named in ArriVent BioPharma, Inc.’s annual report 0
No company named in this filing matched a company in the map.
Companies whose annual reports name ArriVent BioPharma, Inc. 1
“...ions that are currently in clinical trials, including Cullinan Therapeutics in collaboration with Taiho Pharmaceutical, ArriVent BioPharma in collaboration with Allist Pharmaceuticals, Black Diamond Therapeutics, Scorpion Therapeutics in collaboration with Pierre Fabre, BlossomHill Therapeutics, Avi...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.